Z-Blastin 10mg/ml (Vinblastine sulphate Vials) 10mg/10ml

Z-Blastin 10mg/ml (Vinblastine sulphate) is an injectable chemotherapy medication used to treat various cancers. This 10mg/10ml vial form from Zuvius Life Sciences is stored between 2-8°C. Vinblastine sulphate is a key chemotherapy agent in cancer treatment protocols.

Strength

10mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Zuvius Life Sciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vinblastine sulphate, the active ingredient in Z-Blastin 10mg/ml, is primarily used to treat Hodgkin's lymphoma, non-Hodgkin's lymphoma, and certain types of testicular cancer. It may also be prescribed for Kaposi's sarcoma, breast cancer, or lung cancer in specific treatment regimens. This medication works by interfering with cancer cell growth and division.

Side Effects

Z-Blastin 10mg/ml may cause temporary side effects such as nausea, vomiting, or fatigue after administration. Some patients report mild hair thinning or changes in blood cell counts during treatment. These effects vary by individual and typically resolve after therapy completion.

Precautions & Warnings

Store Z-Blastin 10mg/ml vials refrigerated between 2-8°C and protect from light. Handle with care using proper medical protocols as this is a cytotoxic medication. Avoid exposure during pregnancy and inform your healthcare provider about all current medications before use.

Avoid Interactions

Z-Blastin 10mg/ml may interact with medications that affect liver enzymes, such as certain antifungals or antibiotics. Combining with other chemotherapy drugs or radiation therapy requires medical supervision. Alcohol consumption should be discussed with your doctor during treatment.

References

Frequently Asked Questions

Vinblastine sulphate is primarily used to treat various cancers including Hodgkin's lymphoma, non-Hodgkin's lymphoma, and testicular cancer.

Store between 2-8°C and protect from light. Do not freeze and discard any unused portion after opening.

Vinblastine sulphate requires a prescription and should only be obtained through licensed medical suppliers or pharmacies.

Common effects may include nausea, fatigue, or temporary changes in blood cell counts during treatment.

This medication should be avoided during pregnancy as it may harm the developing fetus. Always consult your healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.